Kristian A. Werling

With decades of dealmaking experience on both the buy-side and sell-side, Krist puts clients in a prime position to outpace the competition. Whether working across international borders or diving deep into specialized subsectors, he connects stakeholders and structures creative solutions that others might overlook. His experience in sector-specific due diligence and regulatory nuances anticipates obstacles before they materialize, helping transactions succeed and clients achieve sustainable, long-term growth.

He has led cutting-edge industry transactions that have introduced cancer and gene therapy products to the global market, expanded access to fertility services, increased the availability of cost-effective outpatient surgical services, and transformed the delivery of physician services in a broad range of specialties.

See Less

• United Digestive Holdings in its acquisition of GastroMD
• TJC, L.P. in acquisitions including Switchback Medical, LightningCath., and Proto Lase
• Shore Capital Partners in the formation of PhaseWell Research and acquisitions including Gabrail Cancer Center Research; Renstar Medical Research; and Chase Medical Research
• Linden Capital Partners in its investment in Klick Group
• Compass Surgical Partners, LLC in its partnership and strategic investment from TPG Growth
• Viscogliosi Brothers, LLC and its affiliate VB Spine LLC in its acquisition of Stryker Corporation’s implant business and the anticipated acquisition of Stryker’s spinal implants business in France and other international markets
• Cleveland Clinic, Hospital for Special Surgery and Northwestern Medicine in strategic innovation investments and joint ventures
• Assured Healthcare Partners in its investment in Tandem Clinical Research, the formation of Prolerity Clinical Research, and its partnership with Allied Digestive Health.
• Valinor Pharma and Healthcare Royalty Partners in the cross-border sale of US-based Valinor Pharma to German-based Grünenthal for approximately $250 million in upfront cash consideration
• Amulet Capital Partners in transactions including US Fertility, Choice Healthcare Services, Unlock Health, Theoria Management, LLC, Genetics & IVF Institute, Inc. (GIVF) and its affiliates, Fairfax Eggbank and Fairfax Cryobank; Eruptr Holdings, Inc.; and United Vein & Vascular Centers

See Less

• LMG Life Sciences’ 2015 “Collaboration Deal of the Year,” for representation of Baxalta in a global license and collaboration with Merrimack Pharmaceuticals
• The M&A Advisor, Top 40 Under 40 Legal Advisors 2015

See Less